Europe — EMA
Noradrenaline (Norepinephrine) Aguettant (Noradrenaline Tartrate)
GNH USA supplies Noradrenaline (Norepinephrine) Aguettant, a vasopressor for acute hypotension, shock and cardiac arrest. Request a quote for global supply.
Request sourcing
What is Noradrenaline Tartrate?
Noradrenaline Tartrate, the active ingredient in Noradrenaline (Norepinephrine) Aguettant, is an adrenergic agonist presented as an injectable solution for intravenous use. It is employed to raise blood pressure in patients with acute hypotension, various forms of shock, and during cardiac arrest in critical care settings.
GNH USA supplies Noradrenaline (Norepinephrine) Aguettant as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide, with established cold‑chain logistics and regulatory expertise to meet diverse market requirements.
What is Noradrenaline Tartrate used for?
Noradrenaline (norepinephrine) is an adrenergic vasopressor used to manage conditions characterized by low blood pressure.
- Acute hypotension: restores systemic vascular resistance and improves perfusion pressure. - Cardiogenic shock: supports hemodynamics by increasing cardiac output and arterial pressure. - Cardiac arrest: provides immediate vasoconstriction to facilitate coronary and cerebral perfusion during resuscitation.
What are the side effects of Noradrenaline Tartrate?
Noradrenaline may be associated with a range of adverse reactions, varying from frequent to rare but serious.
Common Side Effects: - Headache: transient headache due to vascular changes. - Tachycardia: increased heart rate. - Arrhythmia: ectopic beats or rhythm disturbances. - Extravasation: local pain and tissue irritation at the infusion site.
Serious or Rare Side Effects: - Severe hypertension: excessive rise in blood pressure. - Myocardial ischemia: reduced coronary perfusion leading to chest pain. - Peripheral ischemia: tissue necrosis from prolonged vasoconstriction. - Cardiac arrest: paradoxical event in susceptible patients.
What precautions apply to Noradrenaline Tartrate?
When using Noradrenaline, careful monitoring and specific safety measures are required.
- Dose titration: adjust infusion rate to achieve target mean arterial pressure. - Cardiovascular monitoring: continuously monitor blood pressure and heart rhythm. - Extravasation risk: avoid infiltration; stop infusion immediately if signs appear. - Use in pregnancy: only if benefit outweighs risk; limited data available. - Drug compatibility: verify compatibility with IV solutions and other medications. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.
What does Noradrenaline Tartrate interact with?
Noradrenaline can interact with several drug classes, necessitating vigilance.
Major Interactions (Avoid): - MAO inhibitors: risk of hypertensive crisis. - Tricyclic antidepressants: additive sympathomimetic effects. - Beta‑blockers: may blunt desired cardiac response. - Vasopressin: excessive vasoconstriction.
Moderate Interactions (Monitor Closely): - Diuretics: may enhance hypotensive episodes after discontinuation. - Calcium channel blockers: may affect vascular tone. - Opioids: may mask signs of hypertension.



